Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 15656

AbstractMaterial and MethodsResultsDiscussionConclusionKey MessageAcknowledgementReferences
Article in PDF How to Cite Citation Manager Readers' Comments (0) Audio Visual Article Statistics Link to PUBMED Print this Article Send to a Friend
Advertisers Access Statistics Resources

Dr Mohan Z Mani

"Thank you very much for having published my article in record time.I would like to compliment you and your entire staff for your promptness, courtesy, and willingness to be customer friendly, which is quite unusual.I was given your reference by a colleague in pathology,and was able to directly phone your editorial office for clarifications.I would particularly like to thank the publication managers and the Assistant Editor who were following up my article. I would also like to thank you for adjusting the money I paid initially into payment for my modified article,and refunding the balance.
I wish all success to your journal and look forward to sending you any suitable similar article in future"



Dr Mohan Z Mani,
Professor & Head,
Department of Dermatolgy,
Believers Church Medical College,
Thiruvalla, Kerala
On Sep 2018




Prof. Somashekhar Nimbalkar

"Over the last few years, we have published our research regularly in Journal of Clinical and Diagnostic Research. Having published in more than 20 high impact journals over the last five years including several high impact ones and reviewing articles for even more journals across my fields of interest, we value our published work in JCDR for their high standards in publishing scientific articles. The ease of submission, the rapid reviews in under a month, the high quality of their reviewers and keen attention to the final process of proofs and publication, ensure that there are no mistakes in the final article. We have been asked clarifications on several occasions and have been happy to provide them and it exemplifies the commitment to quality of the team at JCDR."



Prof. Somashekhar Nimbalkar
Head, Department of Pediatrics, Pramukhswami Medical College, Karamsad
Chairman, Research Group, Charutar Arogya Mandal, Karamsad
National Joint Coordinator - Advanced IAP NNF NRP Program
Ex-Member, Governing Body, National Neonatology Forum, New Delhi
Ex-President - National Neonatology Forum Gujarat State Chapter
Department of Pediatrics, Pramukhswami Medical College, Karamsad, Anand, Gujarat.
On Sep 2018




Dr. Kalyani R

"Journal of Clinical and Diagnostic Research is at present a well-known Indian originated scientific journal which started with a humble beginning. I have been associated with this journal since many years. I appreciate the Editor, Dr. Hemant Jain, for his constant effort in bringing up this journal to the present status right from the scratch. The journal is multidisciplinary. It encourages in publishing the scientific articles from postgraduates and also the beginners who start their career. At the same time the journal also caters for the high quality articles from specialty and super-specialty researchers. Hence it provides a platform for the scientist and researchers to publish. The other aspect of it is, the readers get the information regarding the most recent developments in science which can be used for teaching, research, treating patients and to some extent take preventive measures against certain diseases. The journal is contributing immensely to the society at national and international level."



Dr Kalyani R
Professor and Head
Department of Pathology
Sri Devaraj Urs Medical College
Sri Devaraj Urs Academy of Higher Education and Research , Kolar, Karnataka
On Sep 2018




Dr. Saumya Navit

"As a peer-reviewed journal, the Journal of Clinical and Diagnostic Research provides an opportunity to researchers, scientists and budding professionals to explore the developments in the field of medicine and dentistry and their varied specialities, thus extending our view on biological diversities of living species in relation to medicine.
‘Knowledge is treasure of a wise man.’ The free access of this journal provides an immense scope of learning for the both the old and the young in field of medicine and dentistry as well. The multidisciplinary nature of the journal makes it a better platform to absorb all that is being researched and developed. The publication process is systematic and professional. Online submission, publication and peer reviewing makes it a user-friendly journal.
As an experienced dentist and an academician, I proudly recommend this journal to the dental fraternity as a good quality open access platform for rapid communication of their cutting-edge research progress and discovery.
I wish JCDR a great success and I hope that journal will soar higher with the passing time."



Dr Saumya Navit
Professor and Head
Department of Pediatric Dentistry
Saraswati Dental College
Lucknow
On Sep 2018




Dr. Arunava Biswas

"My sincere attachment with JCDR as an author as well as reviewer is a learning experience . Their systematic approach in publication of article in various categories is really praiseworthy.
Their prompt and timely response to review's query and the manner in which they have set the reviewing process helps in extracting the best possible scientific writings for publication.
It's a honour and pride to be a part of the JCDR team. My very best wishes to JCDR and hope it will sparkle up above the sky as a high indexed journal in near future."



Dr. Arunava Biswas
MD, DM (Clinical Pharmacology)
Assistant Professor
Department of Pharmacology
Calcutta National Medical College & Hospital , Kolkata




Dr. C.S. Ramesh Babu
" Journal of Clinical and Diagnostic Research (JCDR) is a multi-specialty medical and dental journal publishing high quality research articles in almost all branches of medicine. The quality of printing of figures and tables is excellent and comparable to any International journal. An added advantage is nominal publication charges and monthly issue of the journal and more chances of an article being accepted for publication. Moreover being a multi-specialty journal an article concerning a particular specialty has a wider reach of readers of other related specialties also. As an author and reviewer for several years I find this Journal most suitable and highly recommend this Journal."
Best regards,
C.S. Ramesh Babu,
Associate Professor of Anatomy,
Muzaffarnagar Medical College,
Muzaffarnagar.
On Aug 2018




Dr. Arundhathi. S
"Journal of Clinical and Diagnostic Research (JCDR) is a reputed peer reviewed journal and is constantly involved in publishing high quality research articles related to medicine. Its been a great pleasure to be associated with this esteemed journal as a reviewer and as an author for a couple of years. The editorial board consists of many dedicated and reputed experts as its members and they are doing an appreciable work in guiding budding researchers. JCDR is doing a commendable job in scientific research by promoting excellent quality research & review articles and case reports & series. The reviewers provide appropriate suggestions that improve the quality of articles. I strongly recommend my fraternity to encourage JCDR by contributing their valuable research work in this widely accepted, user friendly journal. I hope my collaboration with JCDR will continue for a long time".



Dr. Arundhathi. S
MBBS, MD (Pathology),
Sanjay Gandhi institute of trauma and orthopedics,
Bengaluru.
On Aug 2018




Dr. Mamta Gupta,
"It gives me great pleasure to be associated with JCDR, since last 2-3 years. Since then I have authored, co-authored and reviewed about 25 articles in JCDR. I thank JCDR for giving me an opportunity to improve my own skills as an author and a reviewer.
It 's a multispecialty journal, publishing high quality articles. It gives a platform to the authors to publish their research work which can be available for everyone across the globe to read. The best thing about JCDR is that the full articles of all medical specialties are available as pdf/html for reading free of cost or without institutional subscription, which is not there for other journals. For those who have problem in writing manuscript or do statistical work, JCDR comes for their rescue.
The journal has a monthly publication and the articles are published quite fast. In time compared to other journals. The on-line first publication is also a great advantage and facility to review one's own articles before going to print. The response to any query and permission if required, is quite fast; this is quite commendable. I have a very good experience about seeking quick permission for quoting a photograph (Fig.) from a JCDR article for my chapter authored in an E book. I never thought it would be so easy. No hassles.
Reviewing articles is no less a pain staking process and requires in depth perception, knowledge about the topic for review. It requires time and concentration, yet I enjoy doing it. The JCDR website especially for the reviewers is quite user friendly. My suggestions for improving the journal is, more strict review process, so that only high quality articles are published. I find a a good number of articles in Obst. Gynae, hence, a new journal for this specialty titled JCDR-OG can be started. May be a bimonthly or quarterly publication to begin with. Only selected articles should find a place in it.
An yearly reward for the best article authored can also incentivize the authors. Though the process of finding the best article will be not be very easy. I do not know how reviewing process can be improved. If an article is being reviewed by two reviewers, then opinion of one can be communicated to the other or the final opinion of the editor can be communicated to the reviewer if requested for. This will help one’s reviewing skills.
My best wishes to Dr. Hemant Jain and all the editorial staff of JCDR for their untiring efforts to bring out this journal. I strongly recommend medical fraternity to publish their valuable research work in this esteemed journal, JCDR".



Dr. Mamta Gupta
Consultant
(Ex HOD Obs &Gynae, Hindu Rao Hospital and associated NDMC Medical College, Delhi)
Aug 2018




Dr. Rajendra Kumar Ghritlaharey

"I wish to thank Dr. Hemant Jain, Editor-in-Chief Journal of Clinical and Diagnostic Research (JCDR), for asking me to write up few words.
Writing is the representation of language in a textual medium i e; into the words and sentences on paper. Quality medical manuscript writing in particular, demands not only a high-quality research, but also requires accurate and concise communication of findings and conclusions, with adherence to particular journal guidelines. In medical field whether working in teaching, private, or in corporate institution, everyone wants to excel in his / her own field and get recognised by making manuscripts publication.


Authors are the souls of any journal, and deserve much respect. To publish a journal manuscripts are needed from authors. Authors have a great responsibility for producing facts of their work in terms of number and results truthfully and an individual honesty is expected from authors in this regards. Both ways its true "No authors-No manuscripts-No journals" and "No journals–No manuscripts–No authors". Reviewing a manuscript is also a very responsible and important task of any peer-reviewed journal and to be taken seriously. It needs knowledge on the subject, sincerity, honesty and determination. Although the process of reviewing a manuscript is a time consuming task butit is expected to give one's best remarks within the time frame of the journal.
Salient features of the JCDR: It is a biomedical, multidisciplinary (including all medical and dental specialities), e-journal, with wide scope and extensive author support. At the same time, a free text of manuscript is available in HTML and PDF format. There is fast growing authorship and readership with JCDR as this can be judged by the number of articles published in it i e; in Feb 2007 of its first issue, it contained 5 articles only, and now in its recent volume published in April 2011, it contained 67 manuscripts. This e-journal is fulfilling the commitments and objectives sincerely, (as stated by Editor-in-chief in his preface to first edition) i e; to encourage physicians through the internet, especially from the developing countries who witness a spectrum of disease and acquire a wealth of knowledge to publish their experiences to benefit the medical community in patients care. I also feel that many of us have work of substance, newer ideas, adequate clinical materials but poor in medical writing and hesitation to submit the work and need help. JCDR provides authors help in this regards.
Timely publication of journal: Publication of manuscripts and bringing out the issue in time is one of the positive aspects of JCDR and is possible with strong support team in terms of peer reviewers, proof reading, language check, computer operators, etc. This is one of the great reasons for authors to submit their work with JCDR. Another best part of JCDR is "Online first Publications" facilities available for the authors. This facility not only provides the prompt publications of the manuscripts but at the same time also early availability of the manuscripts for the readers.
Indexation and online availability: Indexation transforms the journal in some sense from its local ownership to the worldwide professional community and to the public.JCDR is indexed with Embase & EMbiology, Google Scholar, Index Copernicus, Chemical Abstracts Service, Journal seek Database, Indian Science Abstracts, to name few of them. Manuscriptspublished in JCDR are available on major search engines ie; google, yahoo, msn.
In the era of fast growing newer technologies, and in computer and internet friendly environment the manuscripts preparation, submission, review, revision, etc and all can be done and checked with a click from all corer of the world, at any time. Of course there is always a scope for improvement in every field and none is perfect. To progress, one needs to identify the areas of one's weakness and to strengthen them.
It is well said that "happy beginning is half done" and it fits perfectly with JCDR. It has grown considerably and I feel it has already grown up from its infancy to adolescence, achieving the status of standard online e-journal form Indian continent since its inception in Feb 2007. This had been made possible due to the efforts and the hard work put in it. The way the JCDR is improving with every new volume, with good quality original manuscripts, makes it a quality journal for readers. I must thank and congratulate Dr Hemant Jain, Editor-in-Chief JCDR and his team for their sincere efforts, dedication, and determination for making JCDR a fast growing journal.
Every one of us: authors, reviewers, editors, and publisher are responsible for enhancing the stature of the journal. I wish for a great success for JCDR."



Thanking you
With sincere regards
Dr. Rajendra Kumar Ghritlaharey, M.S., M. Ch., FAIS
Associate Professor,
Department of Paediatric Surgery, Gandhi Medical College & Associated
Kamla Nehru & Hamidia Hospitals Bhopal, Madhya Pradesh 462 001 (India)
E-mail: drrajendrak1@rediffmail.com
On May 11,2011




Dr. Shankar P.R.

"On looking back through my Gmail archives after being requested by the journal to write a short editorial about my experiences of publishing with the Journal of Clinical and Diagnostic Research (JCDR), I came across an e-mail from Dr. Hemant Jain, Editor, in March 2007, which introduced the new electronic journal. The main features of the journal which were outlined in the e-mail were extensive author support, cash rewards, the peer review process, and other salient features of the journal.
Over a span of over four years, we (I and my colleagues) have published around 25 articles in the journal. In this editorial, I plan to briefly discuss my experiences of publishing with JCDR and the strengths of the journal and to finally address the areas for improvement.
My experiences of publishing with JCDR: Overall, my experiences of publishing withJCDR have been positive. The best point about the journal is that it responds to queries from the author. This may seem to be simple and not too much to ask for, but unfortunately, many journals in the subcontinent and from many developing countries do not respond or they respond with a long delay to the queries from the authors 1. The reasons could be many, including lack of optimal secretarial and other support. Another problem with many journals is the slowness of the review process. Editorial processing and peer review can take anywhere between a year to two years with some journals. Also, some journals do not keep the contributors informed about the progress of the review process. Due to the long review process, the articles can lose their relevance and topicality. A major benefit with JCDR is the timeliness and promptness of its response. In Dr Jain's e-mail which was sent to me in 2007, before the introduction of the Pre-publishing system, he had stated that he had received my submission and that he would get back to me within seven days and he did!
Most of the manuscripts are published within 3 to 4 months of their submission if they are found to be suitable after the review process. JCDR is published bimonthly and the accepted articles were usually published in the next issue. Recently, due to the increased volume of the submissions, the review process has become slower and it ?? Section can take from 4 to 6 months for the articles to be reviewed. The journal has an extensive author support system and it has recently introduced a paid expedited review process. The journal also mentions the average time for processing the manuscript under different submission systems - regular submission and expedited review.
Strengths of the journal: The journal has an online first facility in which the accepted manuscripts may be published on the website before being included in a regular issue of the journal. This cuts down the time between their acceptance and the publication. The journal is indexed in many databases, though not in PubMed. The editorial board should now take steps to index the journal in PubMed. The journal has a system of notifying readers through e-mail when a new issue is released. Also, the articles are available in both the HTML and the PDF formats. I especially like the new and colorful page format of the journal. Also, the access statistics of the articles are available. The prepublication and the manuscript tracking system are also helpful for the authors.
Areas for improvement: In certain cases, I felt that the peer review process of the manuscripts was not up to international standards and that it should be strengthened. Also, the number of manuscripts in an issue is high and it may be difficult for readers to go through all of them. The journal can consider tightening of the peer review process and increasing the quality standards for the acceptance of the manuscripts. I faced occasional problems with the online manuscript submission (Pre-publishing) system, which have to be addressed.
Overall, the publishing process with JCDR has been smooth, quick and relatively hassle free and I can recommend other authors to consider the journal as an outlet for their work."



Dr. P. Ravi Shankar
KIST Medical College, P.O. Box 14142, Kathmandu, Nepal.
E-mail: ravi.dr.shankar@gmail.com
On April 2011
Anuradha

Dear team JCDR, I would like to thank you for the very professional and polite service provided by everyone at JCDR. While i have been in the field of writing and editing for sometime, this has been my first attempt in publishing a scientific paper.Thank you for hand-holding me through the process.


Dr. Anuradha
E-mail: anuradha2nittur@gmail.com
On Jan 2020

Important Notice

Original article / research
Year : 2008 | Month : October | Volume : 2 | Issue : 5 | Page : 1086 - 1091

Results Of Two Multicentric, Comparative, Randomized, Parallel Group Clinical Trials To Evaluate The Efficacy And Safety Of Dexketoprofen Trometamol In The Treatment Of Dental Pain And Dysmenorrhoea In Indian Patients

BALANI M, GAWADE P, MAHESHGAURI S, GHOLE S, SHINDE V, SATHE V Correspondence Address :
Dr. Balani M. M.A.Rangoonwala College
of Dental Sciences & Research Centre,
2390-B,K.B.Hidayatullahroad, Azam Campus,Corresponding Author
Camp,Pune-411001.
Ph:9422555576,Email:drmanojbalani@gmail.com

Abstract

Background: Dexketoprofen is the active enantiomer of the popular NSAID Ketoprofen which is a 50:50 mixture of S (+) and R (-) enantiomers.
Aims: To demonstrate therapeutic efficacy and safety of Dexketoprofen 25 mg as compared to Ketoprofen 50 mg in patients undergoing dental surgery and in patients with dysmenorrhoea.
Study Design: Multicentric, comparative, randomized, parallel group studies. Materials and Methods: Out patients undergoing third molar extraction were randomized to receive either Dexketoprofen or Ketoprofen. In a separate study, patients with dysmenorrhoea were randomized into similar two groups. Pain intensity as recorded on Visual Analogue Scale before therapy and at regular intervals after therapy was quantified and statistically analysed.
Materials and Methods: Out patients undergoing third molar extraction were randomized to receive either Dexketoprofen or Ketoprofen. In a separate study, patients with dysmenorrhoea were randomized into similar two groups. Pain intensity as recorded on Visual Analogue Scale before therapy and at regular intervals after therapy was quantified and statistically analysed.
Results: In both the studies, the groups were comparable in demographics and baseline pain intensity. Dexketoprofen was as effective as Ketoprofen in relieving pain during menstruation. In case of dental pain, Dexketoprofen provided early onset of statistically significant analgesia as compared to Ketoprofen.
Conclusions: Dexketoprofen (25mg) is as effective as Ketoprofen (50mg) in the treatment of dysmenorrhoea and is a faster and equally safe analgesic in the treatment of acute pain of dental surgery.

Keywords

Dexketoprofen, Ketoprofen, Dental extraction, Dysmenorrhoea

Introduction
Racemic ketoprofen is a 50:50 mixture of S(+)- and R(-)-enantiomer (1). Most or all COX inhibitory activity of ketoprofen is attributed to the S(+)-enantiomer (dexketoprofen) (2). Dexketoprofen is a dual and fairly balanced inhibitor of cyclooxygenase (COX)-1 and COX-2 isoenzymes (3),(4),(5). The R(-)-enantiomer is 30 to 5000 times less potent as an inhibitor of COX-1 and about 100 times less potent as an inhibitor of COX-2 (3). Dexketoprofen has been shown to be effective in the symptomatic treatment of pain of mild to moderate intensity (6), such as musculo-skeletal pain (7),(8), dysmenorrhoea (9), dental pain (10),(11) and osteoarthritis (12),(13),(14).

In a study of clinical comparison of dexketoprofen trometamol, ketoprofen, and placebo in postoperative dental pain (11), the results showed that dexketoprofen trometamol 25 mg is at least as effective as the racemic ketoprofen 50 mg in the treatment of post surgical dental pain. Dexketoprofen trometamol also had a faster onset of action as compared to ketoprofen.

In another study (9), Dexketoprofen in the doses of 12.5 mg and 25 mg was significantly superior to placebo and as effective as Ketoprofen 50 mg in relieving pain due to Dysmenorrhoea. The safety profile was comparable with all the three doses of the study medications.

Present two studies were designed to assess the efficacy and safety of Dexketoprofen trometamol in the treatment of postoperative pain after dental procedure and in the treatment of dysmenorrhoea in Indian patients.

Material and Methods

The dental pain study was conducted by four dental surgeons in India, in their respective out patient departments. A total of 50 patients were enrolled. The study was a multicentric, randomized, parallel group, comparative clinical trial. Male or female patients between 18-65 years of age, undergoing oral surgery consisting of extraction of the impacted or semi-impacted third molars and willing to give written informed consent and willing to comply with trial protocol were included.

The dysmenorrhoea study was conducted by three Gynaecologists in three different towns of India in their respective clinics/ nursing homes, on an out patient basis. Female patients in the age group 18 to 45 years, who were having painful menstruation and in whom empiric NSAID therapy was indicated with the presumptive diagnosis of primary dysmenorrhea, based on a typical history of low anterior pelvic pain beginning in adolescence and associated specifically with menstrual periods were enrolled in the study after obtaining written informed consent. Patients with hypersensitivity and/or contraindications to Ketoprofen or other NSAIDs were not included in the trial. Also patients with a history of peptic ulcers, patients who were required to take other NSAIDs/narcotic analgesics other than study medication, patients with impaired hepatic and/or renal function and patients who were deemed ineligible for any other reason, were excluded from the study. Patients who had taken any other analgesic in the past 24 hours were excluded as were pregnant and lactating women.

Interventions
Both the studies were comparative studies. Patients received treatment with either Dexketoprofen (from Emcure Pharmaceuticals Limited, India) 25mg one tablet TID or Ketoprofen (from Teva Pharmaceuticals, USA) 50mg one Capsule TID, as per randomization schedule. Randomization was done in 5 blocks of 10, as per the computer generated randomization chart (www.randomization.com). Each patient was dispensed a separate sachet containing the study medications adequate for the entire study duration.

The test (Dexketoprofen) and reference (Ketoprofen) medications were provided in coated opaque sachets to conceal the identity of the treatment allocated from the investigator and the patient. The medication sachets were numbered as per the randomization chart. Patients were randomly allocated to the test or reference groups and given random numbers by a study coordinator, who also dispensed the medication sachets with matching random numbers. The random code was unknown to the investigators and patients and was broken after the study was over. Follow-up was ensured by providing clear instructions to patients regarding their visit schedule. Patients were also given patient information sheet to retain with them containing instructions regarding follow-up schedule and frequency.

For the dental pain trial, the patients with impacted or semi-impacted third molar tooth were screened for eligibility and willingness to participate in the study before being included. The dental extraction was performed using standard orthodox procedure for extraction of impacted/semi-impacted third molar. After 2 hours of surgery, the patients were administered the study medication after marking the baseline pain intensity on the visual analogue scale (VAS). The remaining doses were taken by the patients three times a day for three days. At the follow up visit after 3 days of therapy, the patient submitted the marked VAS to the investigator.

Patients with dysmenorrhoea were also randomized into similar two groups but the treatment duration was for 5 days. The patients marked the baseline pain intensity before taking the study medication and thereafter at pre specified intervals. The follow up visit was on the 2nd day and 5th day of therapy.

Efficacy
The dental pain patients were assessed at baseline (at two hours after surgery) and asked to mark the pain intensity on the VAS. The VAS was 100 mm long with 0 = no pain and 100 = maximal pain imaginable. The first dose was then administered. Patients marked the pain intensity on the VAS after 1 hour, 6 hours, and 8 hours of therapy and also on the 2nd and 3rd day. At the follow up visit, the patient diary card with the marked VAS was collected back.

In case of Dysmenorrhoea, baseline pain intensity was recorded on the VAS before administration of the study medication and after the 1st, 2nd and 3rd dose and also on the 2nd, 3rd, 4th and 5th day. At the last follow up visit the patient submitted the marked patient diary card.

The VAS severity score was then quantified by the investigators and recorded in the case record form (CRF). The onset of action (defined as the time required after administration of drug when patient experiences even a slight decrease in pain intensity) and the duration of action (defined as the time after administration of the drug for which the pain intensity remains decreased) were also recorded in the CRF by the physician.

Tolerability
At each follow up visit, any adverse event was inquired into and recording made accordingly. Need for any rescue analgesic was also inquired into each time patients were assessed during the study.

Ethics
The study was conducted in compliance with the ICH GCP regulations and in accordance with the Declaration of Helsinki of 1975 that was revised in 2000 and after each investigator was authorized by the local Ethics Committee. All patients in both the studies provided written informed consent.

Statistics
Standard descriptive analysis including mean and standard deviation (SD) are used for variables such as the height, weight and age. The paired t-test was performed to assess the significance of change in the VAS score from base line as well as between groups efficacy. The significance of the patients’ and doctors’ assessment of the study medication was done using the Chi-square test. For all statistical analyses, p-value <0.05 was considered as statistically significant. Statistical analysis for the efficacy and safety variables was done using the GraphPad InStat software.

Results

Fifty (50) patients were enrolled and also completed the dental pain study. Twenty five patients received Dexketoprofen trometamol 25 mg tablets (1 tablet TID orally) and twenty five received Ketoprofen 50 mg capsules (1 capsule TID orally). There was no significant difference in the baseline characteristics of the two groups of patients (p>0.05) (Table/Fig 1). There was no significant difference in the interventions performed or the antibiotic cover provided after the surgery. In both the groups comparable numbers received either of the four drugs/ drug combinations: Ciprofloxacin, Cefadroxil, Ofloxacin+ Ornidazole or Cefuroxime. There was a statistically significant (p=0.01) improvement in the VAS mean scores for symptoms of pain in the dexketoprofen group after 1 hour as well as 6 hours of administration of first dose whereas in the ketoprofen group, a significant decrease in pain intensity on the visual analogue scale score was observed only after 8 hours of drug administration (Table/Fig 2). Thus dexketoprofen has shown faster onset of significant analgesia as compared to ketoprofen. The comparative difference between the two groups for VAS scores of pain was not statistically significant (p>0.05) at baseline and at 1 hour, 6 hours and at 8 hours after drug administration (Table/Fig 2). However further analysis of the VAS score showed that patients in the dexketoprofen group experienced significantly higher analgesia on the first, second and third days of therapy as compared to the ketoprofen group (Table/Fig 2).There was no significant difference in the onset of analgesia between the two groups, 31.04 ± 24.99 mins for the Dexketoprofen group and 29.32 ± 21.89 mins for the Ketoprofen group (p=0.65). The duration of analgesia was 7.88 ± 3.21 hours and 6.98 ± 3.17 hours (p=0.06) for the Dexketoprofen and the Ketoprofen groups respectively.

In the Dysmenorrhoea study,fifty five (55) patients were enrolled and also completed the study. Twenty eight patients received Dexketoprofen trometamol 25 mg tablets (1 tablet TID orally). Twenty seven received Ketoprofen 50 mg capsules (1 capsule TID orally).There was no significant difference in the baseline characteristics of the two groups of patients (p>0.05) (Table/Fig 3).There was a statistically significant (p<0.01) improvement in the VAS mean scores for symptoms of pain in each group after first dose of the study drugs and also after the second dose, third dose and at 2nd, 3rd, 4th and 5th day of therapy as compared to baseline (before therapy) values (Table/Fig 4). The comparative difference between the two groups for VAS scores of pain was not statistically significant (p>0.05) (Table/Fig 4). The onset of analgesia was 22.68 ± 9.38 mins and 22.96 ± 7.88 mins (p>0.05) for the Dexketoprofen and Ketoprofen groups respectively.

None of the groups in both the studies required any rescue analgesic. None of the patients in either group in both the studies reported any side-effects and both the drugs were well-tolerated. There was no significant difference in the opinion of the patients as well as the investigators regarding the efficacy of either drug.

Discussion

Various clinical trials have demonstrated that Dexketoprofen, the S (+) enantiomer of Ketoprofen, is a quick acting analgesic for the treatment of painful musculoskeletal conditions such as osteoarthritis and low back pain and has also demonstrated favourable efficacy and tolerability profile in the treatment for post-operative pain, toothache and dysmenorrhoea (15).

Our study in Dental pain showed that both Dexketoprofen and Ketoprofen were effective analgesics in post surgical dental pain and significant analgesia was achieved faster with Dexketoprofen than with Ketoprofen. These findings are consistent with the findings of McGurk M et al (11) who concluded that the rapid onset of action of Dexketoprofen trometamol as compared to Ketoprofen makes it a more suitable analgesic for treatment of acute pain.

Our findings in the Dysmenorrhoea study are consistent with the findings of Ezcurdia M et al (9) that Dexketoprofen at half the dose provides analgesia comparable to full dose of racemic Ketoprofen.

For both the indications both the drugs were safe and very well tolerated.

Conclusion

The results of this multi-centric, randomized, comparative clinical trial to evaluate the efficacy and safety of Dexketoprofen trometamol 25 mg versus Ketoprofen 50 mg in the treatment of pain due to dental surgery shows that Dexketoprofen trometamol 25 mg is equally effective as compared to Ketoprofen 50 mg in decreasing pain due to dental extraction in the first 8 hours of therapy. Dexketoprofen has a better analgesic effect at 24 hours and on the second and third day of therapy as compared to Ketoprofen. Dexketoprofen provided significant analgesia within 1 hour of dosing whereas though Ketoprofen decreased the pain intensity at 1 hour, statistically significant analgesia was observed only after 8 hours of therapy with ketoprofen. Both the drugs have similar onset and duration of action and are safe and well-tolerated in this indication.

In case of dysmenorrhoea, Dexketoprofen (25 mg) and Ketoprofen (50 mg) showed equal efficacy in relieving pain and both the drugs were very well tolerated by Indian patients.

Key Message

(1) Chirally pure drugs provide the active ingredient of the drug minus the inactive and sometimes toxic ingredient, thus decreasing the metabolic load on the body, decreasing the side effects and at the same time providing equal or better therapeutic efficacy at half the dose.
(2) Dexketoprofen is the active enantiomer of racemic Ketoprofen and is responsible for all of the Cox-1 and Cox-2 inhibitory activity of ketoprofen.
(3) Dexketoprofen is therapeutically more effective even at half the dose of Ketoprofen in the treatment of pain caused due to dental extraction.
(4) Dexketoprofen 25mg is as effective as Ketoprofen 50mg in relieving the pain of dysmenorrhoea.
(5) Both Dexketoprofen and Ketoprofen are equally safe in Indian patients for these two indications

Acknowledgement

This study was sponsored by Emcure Pharmaceuticals Limited, Pune.

References

1.
. Barbanoj MJ, Gich I, Artigas R, et al: Pharmacokinetics of dexketoprofen trometamol in healthy volunteers after single and repeated oral doses. J Clin Pharmacol 1998; 38:33S-40S.
2.
. Barbanoj MJ. Clinical pharmacokinetics of dexketoprofen trometamol: recent studies. Methods Find Exp Clin Pharmacol 2006; 28(Suppl A): 3-5.
3.
. Mauleon D, Artigas R, Garcia L, et al: Preclinical and clinical development of dexketoprofen. Drug 1996; 52(suppl 5):24-46.
4.
. Cabré F, Fernández MF, Calvo L, Ferrer X, García ML, Mauleón D. Analgesic, antiinflammatory, and antipyretic effects of S(+)-ketoprofen in vivo. J Clin Pharmacol. 1998; 38(12 Suppl):3S-10S.
5.
. Laudanno OM, Piombo G, Cesolari JA, Godoy A, Rocaspana A, Aramberry L. Dexketoprofene, selective cox-1 inhibitor nsaids, without gastrointestinal injury in rats. Acta Gastroenterol Latinoam. 2002; 32(1):17-20.
6.
. Sánchez-Carpena J, Domínguez-Hervella F, García I, Gene E, Bugarín R, Martín A, Tomás-Vecina S, García D, Serrano JA, Roman A, Mariné M, Mosteiro ML. Comparison of intravenous dexketoprofen and dipyrone in acute renal colic. Eur J Clin Pharmacol. 2007; 63(8):751-60.
7.
. P Leman, Y Kapadia, J Herington. Randomised controlled trial of the onset of analgesic efficacy of dexketoprofen and diclofenac in lower limb injury. Emerg Med J 2003; 20:511–513.
8.
. Zippel H, Wagenitz A. A multicentre, randomised, double-blind study comparing the efficacy and tolerability of intramuscular dexketoprofen versus diclofenac in the symptomatic treatment of acute low back pain. Clin Drug Investig 2007; 27(8):533-43.
9.
. Ezcurdia M, Cortejoso FJ, Lanzón R, Ugalde FJ, Herruzo A, Artigas R, Fernández F, Torres F, Mauleón D. J Comparison of the efficacy and tolerability of dexketoprofen and ketoprofen in the treatment of primary dysmenorrhea. Clin Pharmacol 1998; 38(12 Suppl): 65S-73S.
10.
. Jiménez-Martínez E, Gasco-García C, Arrieta-Blanco JJ, Gomez del Torno J, Bartolome Villar B.Study of the analgesic efficacy of Dexketoprofen Trometamol 25mg. vs. Ibuprofen 600mg. after their administration in patients subjected to oral surgery. Med Oral 2004; 9(2):143-8, 138-43.
11.
. McGurk M, Robinson P, Rajayogeswaran V, De Luca M, Casini A, Artigas R, Muñoz G, Mauleón D. Clinical comparison of dexketoprofen trometamol, ketoprofen, and placebo in postoperative dental pain. J Clin Pharmacol 1998; 38(12 Suppl): 46S-54S.
12.
. Beltrán J, Martín-Mola E, Figueroa M, Granados J, Sanmartí R, Artigas R, Torres F, Forns M, Mauleón D.Comparison of dexketoprofen trometamol and ketoprofen in the treatment of osteoarthritis of the knee. J Clin Pharmacol 1998; 38(12 Suppl): 74S-80S.
13.
. Rovetta G, Monteforte P, Brignone A, Molfetta L, Buffrini L. Early-morning administration of dexketoprofen-trometamol in morning stiffness induced by nodal osteoarthritis of the hands. Int J Tissue React 2001; 23(2): 63-6.
14.
. Marenco JL, Pérez M., Navarro FJ, Martínez FG, Beltrán J, Salvatierra D, Alonso A, Ballarín M., Eguidazu I, Zapata A, Horas M, Torres F, Artigas R, Mauleón D. A Multicenter, Randomized, Double-Blind Study to Compare the Efficacy and Tolerability of Dexketoprofen Trometamol versus Diclofenac in the Symptomatic Treatment of Knee Osteoarthritis. Clin Drug Invest 2000; 19(4): 247-56.
15.
. Sweetman BJ. Development and use of the quick acting chiral NSAID dexketoprofen trometamol (keral). Acute Pain 2003; 4:109–15.

JCDR is now Monthly and more widely Indexed .
  • Emerging Sources Citation Index (Web of Science, thomsonreuters)
  • Index Copernicus ICV 2017: 134.54
  • Academic Search Complete Database
  • Directory of Open Access Journals (DOAJ)
  • Embase
  • EBSCOhost
  • Google Scholar
  • HINARI Access to Research in Health Programme
  • Indian Science Abstracts (ISA)
  • Journal seek Database
  • Google
  • Popline (reproductive health literature)
  • www.omnimedicalsearch.com